NAYA Biosciences, Inc.
NASDAQ: NAYA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Steven M. Shum
- Employees
- 30
- Headquarters
- Sarasota, United States
- IPO year
- 2020
- Market cap
- $1.5M
- Website
- http://www.nayabiosciences.com
Loading NAYA…
Loading profile data…Frequently asked questions about NAYA
What does NAYA Biosciences, Inc. (NAYA) do?
INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.
Where does NAYA trade?
NAYA Biosciences, Inc. (NAYA) trades on the NASDAQ Global Market.
What sector is NAYA in?
NAYA Biosciences, Inc. (NAYA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of NAYA Biosciences, Inc.?
Steven M. Shum is the chief executive officer of NAYA Biosciences, Inc. (NAYA).
Where is NAYA Biosciences, Inc. headquartered?
NAYA Biosciences, Inc. is headquartered in United States.
Does NAYA pay a dividend?
NAYA Biosciences, Inc. (NAYA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NAYA go public?
NAYA Biosciences, Inc. (NAYA) completed its initial public offering in 2020.